CME EBITDA Growth
CME Group · EBITDA Growth
CME EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported3.47%period ending
CME TTM EBITDA YoY % (45.63% → 3.47%)
Year-over-year change
High-resolution chart · PNG
CME ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 3.4665% | |
| 16.9359% | |
| 14.6276% | |
| 8.0923% | |
| 12.56% | |
| 11.9254% | |
| 8.0054% | |
| 10.2195% | |
| 8.0007% | |
| 8.6651% | |
| 16.1869% | |
| 12.4678% | |
| 4.3301% | |
| 4.0591% | |
| 2.2848% | |
| 8.3012% | |
| 33.8858% | |
| 31.6806% | |
| 17.0967% | |
| 7.2636% | |
| -13.2003% | |
| -15.7504% | |
| 0.3532% | |
| 1.9907% | |
| 15.413% | |
| 18.1769% | |
| 4.9212% | |
| 11.3254% | |
| 2.9469% | |
| 6.2513% | |
| 11.6558% | |
| 5.1285% | |
| 7.995% | |
| 6.2237% | |
| 8.1702% | |
| 14.9013% | |
| 14.3365% | |
| 17.1199% | |
| 14.4867% | |
| 8.6005% | |
| 11.3242% | |
| 7.2928% | |
| 8.4181% | |
| 17.1217% | |
| 14.0028% | |
| 7.4286% | |
| 6.7069% | |
| -3.5107% | |
| -4.2263% | |
| 0.5507% | |
| -4.243% | |
| -2.1137% | |
| -9.1563% | |
| -9.1413% | |
| -10.1647% | |
| -12.1738% | |
| -0.5505% | |
| 0.2418% | |
| 9.1359% | |
| 16.0754% | |
| 13.7346% | |
| 19.6763% | |
| 16.1054% | |
| 9.68% | |
| 3.1591% | |
| 0.9501% | |
| -1.0678% | |
| 7.2498% | |
| 17.5603% | |
| 26.919% | |
| 50.5582% | |
| 71.0334% | |
| 105.2681% | |
| 89.8585% | |
| 74.4971% | |
| 48.1923% | |
| 22.7684% | |
| 23.1516% | |
| 18.3343% | |
| 25.1103% | |
| 22.4211% | |
| 30.3135% | |
| 33.8429% | |
| 43.237% | |
| 58.8744% | |
| 63.1041% | |
| 71.1798% | |
| 44.3915% | |
| 33.3107% | |
| 27.78% | |
| 22.1551% | |
| 42.9414% | |
| 40.239% | |
| 45.6263% |